Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Feb 27, 2014

Mylan Fourth Quarter 2013 Adjusted Diluted EPS Increases 20% to $0.78 and Full Year Adjusted Diluted EPS Increases 12% to $2.89

Feb 14, 2014

Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL due to the Presence of Particulate Matter and/or Illegible and Missing Lot Number and/or Expiry Date

Feb 11, 2014

Mylan Schedules Fourth Quarter and Year End 2013 Financial Results Conference Call and Live Webcast

Feb 03, 2014

Mylan Launches First Trastuzumab Biosimilar, Hertraz™, in India

Jan 31, 2014

Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India

Jan 23, 2014

Mylan Launches Generic Prandin® Tablets

Jan 09, 2014

Mylan Announces CE Mark for MyT4™ Point-of-Care CD4 Diagnostic Test

Jan 09, 2014

Mylan Launches Generic Myfortic® Delayed-Release Tablets

Jan 08, 2014

Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations

Jan 07, 2014

Mylan Launches Generic Detrol® LA Capsules

Pagination

First page
Previous page
…
Page 46
Page 47
Page 48
Page 49
Current page 50
Page 51
Page 52
Page 53
Page 54
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.